AMBBY
Price
$13.20
Change
+$0.24 (+1.85%)
Updated
Nov 13 closing price
Capitalization
3.54B
Intraday BUY SELL Signals
ANPCF
Price
$0.02
Change
-$0.01 (-33.33%)
Updated
Nov 18 closing price
Capitalization
7.64M
Intraday BUY SELL Signals
Interact to see
Advertisement

AMBBY vs ANPCF

Header iconAMBBY vs ANPCF Comparison
Open Charts AMBBY vs ANPCFBanner chart's image
Ambu A/S
Price$13.20
Change+$0.24 (+1.85%)
Volume$137
Capitalization3.54B
CELLBXHEALTH
Price$0.02
Change-$0.01 (-33.33%)
Volume$200
Capitalization7.64M
AMBBY vs ANPCF Comparison Chart in %
AMBBY
Daily Signal:
Gain/Loss:
ANPCF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AMBBY vs. ANPCF commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMBBY is a Hold and ANPCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (AMBBY: $13.20 vs. ANPCF: $0.02)
Brand notoriety: AMBBY and ANPCF are both not notable
AMBBY represents the Medical/Nursing Services, while ANPCF is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AMBBY: 16% vs. ANPCF: 3%
Market capitalization -- AMBBY: $3.5B vs. ANPCF: $7.21M
AMBBY [@Medical/Nursing Services] is valued at $3.5B. ANPCF’s [@Medical Specialties] market capitalization is $7.21M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $219.36B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B. The average market capitalization across the [@Medical Specialties] industry is $11.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMBBY’s FA Score shows that 0 FA rating(s) are green whileANPCF’s FA Score has 1 green FA rating(s).

  • AMBBY’s FA Score: 0 green, 5 red.
  • ANPCF’s FA Score: 1 green, 4 red.
According to our system of comparison, ANPCF is a better buy in the long-term than AMBBY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMBBY’s TA Score shows that 3 TA indicator(s) are bullish while ANPCF’s TA Score has 1 bullish TA indicator(s).

  • AMBBY’s TA Score: 3 bullish, 6 bearish.
  • ANPCF’s TA Score: 1 bullish, 1 bearish.
According to our system of comparison, ANPCF is a better buy in the short-term than AMBBY.

Price Growth

AMBBY (@Medical/Nursing Services) experienced а +1.85% price change this week, while ANPCF (@Medical Specialties) price change was -9.60% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -4.89%. For the same industry, the average monthly price growth was -7.90%, and the average quarterly price growth was +10.70%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.19%. For the same industry, the average monthly price growth was -2.20%, and the average quarterly price growth was +30.04%.

Industries' Descriptions

@Medical/Nursing Services (-4.89% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Medical Specialties (-3.19% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMBBY($3.54B) has a higher market cap than ANPCF($7.64M). AMBBY YTD gains are higher at: 1.382 vs. ANPCF (-85.963).
AMBBYANPCFAMBBY / ANPCF
Capitalization3.54B7.64M46,315%
EBITDA830MN/A-
Gain YTD1.382-85.963-2%
P/E Ratio37.23N/A-
Revenue5.96BN/A-
Total Cash751MN/A-
Total Debt534MN/A-
FUNDAMENTALS RATINGS
AMBBY vs ANPCF: Fundamental Ratings
AMBBY
ANPCF
OUTLOOK RATING
1..100
8538
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7896
PRICE GROWTH RATING
1..100
8295
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
5030

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANPCF's Valuation (28) in the null industry is significantly better than the same rating for AMBBY (97). This means that ANPCF’s stock grew significantly faster than AMBBY’s over the last 12 months.

ANPCF's Profit vs Risk Rating (100) in the null industry is in the same range as AMBBY (100). This means that ANPCF’s stock grew similarly to AMBBY’s over the last 12 months.

AMBBY's SMR Rating (78) in the null industry is in the same range as ANPCF (96). This means that AMBBY’s stock grew similarly to ANPCF’s over the last 12 months.

AMBBY's Price Growth Rating (82) in the null industry is in the same range as ANPCF (95). This means that AMBBY’s stock grew similarly to ANPCF’s over the last 12 months.

AMBBY's P/E Growth Rating (99) in the null industry is in the same range as ANPCF (100). This means that AMBBY’s stock grew similarly to ANPCF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMBBYANPCF
RSI
ODDS (%)
Bullish Trend 2 days ago
51%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
53%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
36%
MACD
ODDS (%)
Bearish Trend 3 days ago
68%
Bullish Trend 2 days ago
10%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
54%
Bearish Trend 2 days ago
34%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
24%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 15 days ago
74%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
51%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
69%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AMBBY
Daily Signal:
Gain/Loss:
ANPCF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSDAX24.80N/A
N/A
Fidelity Select Defense & Aerospace
GSMSX36.10N/A
N/A
Goldman Sachs Mid Cap Value Svc
NSMCX26.94N/A
N/A
Nuveen Small/Mid-Cap Value C
DMCYX31.38N/A
N/A
BNY Mellon Opportunistic Midcap Value Y
PEQSX38.97-0.08
-0.20%
Putnam Large Cap Value R6

AMBBY and

Correlation & Price change

A.I.dvisor tells us that AMBBY and AZTA have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMBBY and AZTA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMBBY
1D Price
Change %
AMBBY100%
N/A
AZTA - AMBBY
24%
Poorly correlated
+0.20%
CLPBY - AMBBY
23%
Poorly correlated
+2.02%
GNNDY - AMBBY
23%
Poorly correlated
-4.78%
ALGN - AMBBY
23%
Poorly correlated
-0.26%
VTAK - AMBBY
21%
Poorly correlated
-1.67%
More

ANPCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANPCF has been loosely correlated with ANPCY. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ANPCF jumps, then ANPCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANPCF
1D Price
Change %
ANPCF100%
-9.60%
ANPCY - ANPCF
58%
Loosely correlated
-2.84%
CATX - ANPCF
26%
Poorly correlated
+3.17%
BLOZF - ANPCF
21%
Poorly correlated
-1.94%
ADMT - ANPCF
5%
Poorly correlated
-6.89%
AMBBY - ANPCF
1%
Poorly correlated
N/A
More